Literature DB >> 8756584

The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes.

T W Gettys1, P J Harkness, P M Watson.   

Abstract

Various model systems have been used to study the expression of the recently cloned ob gene, leptin. Here we report that freshly isolated rat white adipocytes incubated with insulin release leptin in a rapid and concentration-dependent manner (EC50 of 0.221 +/- .075 nM). Insulin-stimulated leptin release could be detected as early as 30 min and a maximal 2-3 fold effect was produced by 10 nM insulin. The effect of insulin was completely blocked by simultaneous activation of cAMP-dependent protein kinase. Using the activation of lipolysis as an index of cAMP-dependent protein kinase activity, we show that inhibition of leptin release by norepinephrine or the selective beta 3-adrenergic receptor agonist, CL316,243, occurred in parallel to activation of cAMP-dependent protein kinase. In addition, beta 1- and beta 2-adrenergic receptor antagonists did not impair the ability of norepinephrine or CL316,243 to inhibit leptin release from the adipocytes. These findings suggest that the beta 3-adrenergic receptor plays a central role in regulating the release of leptin from the adipocyte.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756584     DOI: 10.1210/endo.137.9.8756584

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

1.  Metabolism: Light on leptin link to lipolysis.

Authors:  Johan Ruud; Jens C Brüning
Journal:  Nature       Date:  2015-11-05       Impact factor: 49.962

Review 2.  Adrenoceptors in white, brown, and brite adipocytes.

Authors:  Bronwyn A Evans; Jon Merlin; Tore Bengtsson; Dana S Hutchinson
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

3.  Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.

Authors:  D R Murdoch; E Rooney; H J Dargie; D Shapiro; J J Morton; J J McMurray
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

Review 4.  Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target.

Authors:  Reza Aghamohammadzadeh; Sarah Withers; Fiona Lynch; Adam Greenstein; R Malik; Anthony Heagerty
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

5.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

6.  Central insulin action regulates peripheral glucose and fat metabolism in mice.

Authors:  Linda Koch; F Thomas Wunderlich; Jost Seibler; A Christine Könner; Brigitte Hampel; Sigrid Irlenbusch; Georg Brabant; C Ronald Kahn; Frieder Schwenk; Jens C Brüning
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 7.  Implications of crosstalk between leptin and insulin signaling during the development of diet-induced obesity.

Authors:  Christopher D Morrison; Peter Huypens; Laura K Stewart; Thomas W Gettys
Journal:  Biochim Biophys Acta       Date:  2008-09-25

8.  Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.

Authors:  Joseph Tam; Resat Cinar; Jie Liu; Grzegorz Godlewski; Daniel Wesley; Tony Jourdan; Gergő Szanda; Bani Mukhopadhyay; Lee Chedester; Jeih-San Liow; Robert B Innis; Kejun Cheng; Kenner C Rice; Jeffrey R Deschamps; Robert J Chorvat; John F McElroy; George Kunos
Journal:  Cell Metab       Date:  2012-07-26       Impact factor: 27.287

9.  Leptin, catecholamines and free fatty acids related to reduced recovery delays after training.

Authors:  François Denis Desgorces; Mounir Chennaoui; Danielle Gomez-Merino; Catherine Drogou; Dominique Bonneau; Charles Yannick Guezennec
Journal:  Eur J Appl Physiol       Date:  2004-08-04       Impact factor: 3.078

Review 10.  Emerging role of adipose tissue hypoxia in obesity and insulin resistance.

Authors:  J Ye
Journal:  Int J Obes (Lond)       Date:  2008-12-09       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.